GTC Biotherapeutics (fka GTCB)

[biopearl]

Hi Jesse, What better source than Dr. Cox himself who has as much said that we are talking to one or more partners. I perhaps naively think of the US government (via Pharmathene) as one holder of the GTCB "insurance policy" and the other being the French government via LFB, pretty good indirect partners with a lot to lose if GTCB goes under. They among others want us to succeed. Flo says the MM-093 has no or few side effects and the study continues in open label fashion. This too should tell us something, that being that patients WANT to continue to have access to the drug and are willing to continue in the study. I am with you in concluding that Dr. Cox is a man of honor and ability and will come through. Call me a putz.